Literature DB >> 21822908

Age and gender may affect posterior reversible encephalopathy syndrome in renal disease.

Akio Yamada1, Norishi Ueda.   

Abstract

It remains elusive what factors affect posterior reversible encephalopathy syndrome (PRES). Eleven PRES children, all with acute glomerulonephritis, Alport syndrome, and lupus nephritis, 5 with nephrosis, and 3 renal transplant recipients, were studied. PRES recurred in 1 patient. Neurological symptoms were graded as 1: mild (headache, nausea/vomiting, or tremor), 2: moderate (vision change), and 3: severe (mental dysfunction, cerebellar symptoms, seizures, recurrence of seizures, and coma). Magnetic resonance imaging was graded as 1: subtle change, 2: abnormal large areas, and 3: complete involvement of the regions. The common symptoms were seizures (100%), headache (82%), nausea/vomiting (73%), coma (55%), and vision change (46%). Seizures recurred in 7 (64%). All but one (91%) developed hypertension and 7 (64%) received calcineurin inhibitors (CNI). Edema occurred in 7 (64%) and renal insufficiency/end-stage renal disease (ESRD) in 4 (36%). Seizures recurred frequently in younger patients. Symptoms were severe in girls. Duration or severity of the condition with predisposing factors (hypertension, CNI, nephrosis or renal insufficiency/ERSD) did not make a difference in the symptoms and neuroimaging. Two patients developed chronic epilepsy. Age and gender may affect PRES symptoms. Our results are limited by small sample size and should be determined using larger numbers of patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21822908     DOI: 10.1007/s00467-011-1974-y

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  31 in total

1.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

Review 2.  Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825

3.  Seizures following renal transplantation in childhood.

Authors:  A Q Awan; M A Lewis; R J Postlethwaite; N J Webb
Journal:  Pediatr Nephrol       Date:  1999-05       Impact factor: 3.714

4.  Posterior reversible encephalopathy syndrome: associated clinical and radiologic findings.

Authors:  Jennifer E Fugate; Daniel O Claassen; Harry J Cloft; David F Kallmes; Osman S Kozak; Alejandro A Rabinstein
Journal:  Mayo Clin Proc       Date:  2010-05       Impact factor: 7.616

Review 5.  Cyclosporine neurotoxicity: a review.

Authors:  J M Gijtenbeek; M J van den Bent; C J Vecht
Journal:  J Neurol       Date:  1999-05       Impact factor: 4.849

6.  Posterior Reversible Encephalopathy Syndrome (PRES) in 5-year-old girl with nephrotic syndrome.

Authors:  Pavel Kabicek; Stepan Sulek; Zdenek Seidl; Manuela Vaneckova; Edita Kabickova; Vaclav Vobruba; Laszlo Wenchich; Jiri Zeman
Journal:  Neuro Endocrinol Lett       Date:  2010       Impact factor: 0.765

7.  Posterior reversible encephalopathy syndrome in childhood cancer.

Authors:  P de Laat; M L Te Winkel; A S Devos; C E Catsman-Berrevoets; R Pieters; M M van den Heuvel-Eibrink
Journal:  Ann Oncol       Date:  2010-08-10       Impact factor: 32.976

8.  Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors.

Authors:  Jane P F Bai; Lawrence J Lesko; Gilbert J Burckart
Journal:  Pharmacotherapy       Date:  2010-02       Impact factor: 4.705

9.  Developmental differences in white matter architecture between boys and girls.

Authors:  Vincent J Schmithorst; Scott K Holland; Bernard J Dardzinski
Journal:  Hum Brain Mapp       Date:  2008-06       Impact factor: 5.038

10.  Autoregulation of cerebral blood flow: influence of local brain development and postnatal age.

Authors:  U I Tuor; D Grewal
Journal:  Am J Physiol       Date:  1994-12
View more
  6 in total

Review 1.  Posterior reversible encephalopathy syndrome in children with kidney disease.

Authors:  Cristina Gavrilovici; Ingrith Miron; Luminiţa Voroneanu; Silvia Bădărau; Magdalena Stârcea
Journal:  Int Urol Nephrol       Date:  2017-08-23       Impact factor: 2.370

2.  A case of acute post-streptococcal glomerulonephritis that developed posterior reversible encephalopathy syndrome.

Authors:  Belde Kasap; Kürşat Bora Çarman; Uluç Yiş
Journal:  Turk Pediatri Ars       Date:  2014-12-01

3.  The clinical characteristics of posterior reversible encephalopathy syndrome in patients with chronic renal failure.

Authors:  Hongtao Hu; Shen Xu; Shuang Hu; Weijia Xu; Hua Shui
Journal:  Exp Ther Med       Date:  2017-06-08       Impact factor: 2.447

4.  Clinical and radiological spectrum of posterior reversible encephalopathy syndrome: does age make a difference?--A retrospective comparison between adult and pediatric patients.

Authors:  Eberhard Siebert; Georg Bohner; Matthias Endres; Thomas G Liman
Journal:  PLoS One       Date:  2014-12-16       Impact factor: 3.240

Review 5.  Calcineurin Inhibitors Associated Posterior Reversible Encephalopathy Syndrome in Solid Organ Transplantation: Report of 2 Cases and Literature Review.

Authors:  Turun Song; Zhengsheng Rao; Qiling Tan; Yang Qiu; Jinpeng Liu; Zhongli Huang; Xianding Wang; Tao Lin
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

6.  PRES in the course of hemato-oncological treatment in children.

Authors:  Katarzyna Musioł; Sylwia Waz; Michał Boroń; Magdalena Kwiatek; Magdalena Machnikowska-Sokołowska; Katarzyna Gruszczyńska; Grażyna Sobol-Milejska
Journal:  Childs Nerv Syst       Date:  2017-12-02       Impact factor: 1.475

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.